Bibliography: International Policy Issues

The present report aims to analyze the most common perceptions and fears, contrast them with available evidence on drugs and the people who use them, and provides recommendations on changes that must be enacted to support reforms toward more effective drug policies (The Global Commission on Drug Policy)

In May 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil), through a joint assessment (EMCDDA)

Covering activities during 2016

Health and social responses to drug problems: a European guide is designed to provide an overview of actions or interventions undertaken to address the negative consequences associated with the illicit drug phenomenon (EMCDDA)

This document summarises the main issues concerning evaluation in the field of drug policy. Aimed at those managing rather than undertaking drug policy evaluations, the guide acts as an introduction, providing links to the wider literature (EMCDDA)

To support those considering or involved in commissioning, managing or undertaking policy evaluations, this provides access to a range of materials, including a 7-step guide, examples of strategies and evaluations in Europe and potentially useful data sources (EMCDDA)

This week, the EU has reacted to serious concerns over the use of the synthetic opioid acryloylfentanyl by deciding to subject it to ‘control measures’ throughout the Union (EMCDDA)

Beginning with an overview of the synthetics market, this Policy Report examines the possible sources of such inertia and critically explores the issues underlying what in many respects represents a key yet largely under discussed feature of the extant international drug control system (GDPO)

The two bodies recognise that information on the drug phenomenon is an essential and indispensable instrument for drafting and implementing drug policies and for assessing the impact of actions to reduce problems originating from drug use and trafficking

The Plan sets out the Actions that will be implemented to achieve the objectives of the Strategy (EUR-Lex)

This report presents the key activities performed by the EMCDDA and Europol in 2016 and the results of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances, including new psychoactive substances notified in 2016 (EMCDDA)